Back

Clinical predictors of time-to-first appropriate implantable cardioverter-defibrillator discharge in high-risk patients with Brugada syndrome implanted prophylactically: analysis of 246 patients from

18 June 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Sudden cardiac death and implantable defibrillators Primary prevention (Sudden cardiac death and implantable defibrillators) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Bernard Belhassen

Hadassah-Hebrew University, Jerusalem (Israel)

13 More presentations in this session

Presentation thumbnail
Doctor A. Tronconi (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Doctor J. Acosta Martinez (Seville, ES)
Abstract
Presentation thumbnail
Doctor J. Acosta Martinez (Seville, ES)
Abstract
Presentation thumbnail
Doctor A. Marinheiro (Setubal, PT)
Abstract
Presentation thumbnail
Miss A. Ayemon (Southampton, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Sudden cardiac death and implantable defibrillators

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Asymptomatic Brugada patients: long-term prognosis from a large prospective study.
27 August 2023
thumbnail
Congress Presentation
Development of a risk stratification score based on social predictors in patients undergoing implantable cardioverter defibrillator
29 June 2021
thumbnail
Congress Presentation
3 September 2019
thumbnail
Congress Presentation
Epicardial ablation in patients with Brugada syndrome: a single centre experience
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources